The bank also placed a price target of $52 on Illumina's stock.

Okinawa Institute of Science and Technology says the new faculty members will focus on neuroscience, molecular science, mathematical and computational biology, and environmental science, with the goal of developing interdisciplinary research as OIST transitions into a graduate research university by 2012.

Many in the genetic testing industry have viewed the Bilski decision as a harbinger of the Supreme Court's thinking for future patent cases, including the anti-gene patenting suit filed against Myriad Genetics.

The Supreme Court's decision to send Prometheus v. Mayo back to the Federal Circuit gives the lower court an opportunity to come up with new methods for determining patentability with regard to advanced technologies. But nothing in the Supreme Court's recent actions sheds light on how the courts might deal with method patents related to genetic testing.

"Myriad is very much a player in the field of companion diagnostics," Myriad Genetics CEO Peter Meldrum told investors at the Goldman Sachs annual global healthcare conference earlier this month.

PGXL has become a preferred lab conducting pharmacogenomics testing for CVS Caremark's personalized medicine programs.

Response Genetics' ResponseDX: Lung

Kamran Alam, Stan Lapidus

An Arabic-language science-based reality show aims to educate and innovate.

Universities are trying to help overcome the "valley of death" between a good academic idea and a viable business.

The Open Science Summit will discuss synthetic biology, DIY science, and science publishing, among other topics.

A House committee is attempting to help University of California postdocs with their compensation issues.

Gerald Fink is the 2010 Gruber Genetics Prize winner.

A computer scientist says that bioinformatic databases could learn a lot from search engines that index Chinese Web sites.

In Genome Biology this week: analyzing repetitive elements from short-read sequencing data, molecular evolution of avian genes, whole-exome sequence capture with 'as little as 3 Gbp of raw sequence data,' and more.

RainDance's Sequence Enrichment application enhances SeqWright's targeted resequencing and whole-genome sequencing capabilities for studying disease pathways, cancer, and other areas of research, SeqWright said.

The agreement formalizes a marketing partnership with GeneDiagnostics to sell the ColonSentry test in certain parts of China.

The firm is placing 7 million shares with a private investment partnership. It has not stated its intended use for the proceeds.

The cuts were necessary to take advantage of a "window of opportunity" in miRNA discovery that could enable the firm to enter the molecular diagnostics market.

The supplementary array will enable customers who have adopted the firm's recently launched HumanOmni2.5-Quad DNA Analysis BeadChip to access the new rare variant content provided on the HumanOmni5, which is scheduled to be launched later this year.

In September the company plans to begin selling 96-well CytooPlates, followed soon thereafter with 384-well plates that contain cells patterned using its internally developed technology. It also plans to expand its CytooChips line, in particular to support fluorescence labeling.

Potsdam-based Signature Dx plans to launch by the fourth quarter of this year two array-based in vitro diagnostics for colorectal cancer. The company will first launch the tests in Europe and intends to seek US regulatory approval at an unspecified time in the future.

The study by the European Society of Human Reproduction and Embryology's task force on pre-implantation genetic screening confirmed that 24sure could predict abnormalities in 89 percent of cases.

Researchers from the University of Washington have published a proof-of-principle study on the use of genomic capture and high-throughput sequencing for finding mutations in breast and ovarian cancer risk genes.

A number of molecular diagnostic tests that were cleared for emergency use during the 2009 H1N1 influenza pandemic will have to seek full FDA clearance now that HHS has declared the emergency over.